Navigation Links
AAPCC Issues Statement on Decision of Procter & Gamble to Redesign Tide Pods Packaging
Date:7/12/2013

Alexandria, VA (PRWEB) July 12, 2013

On July 11, Procter & Gamble announced it has redesigned the packaging of its single-load highly concentrated laundry detergent packets. In response, AAPCC President Marsha Ford, MD, FACMT, FACEP, issued the following statement:

“We have learned that Procter & Gamble has decided to redesign the packaging of Tide Pods, its single-load highly concentrated laundry detergent packets. The American Association of Poison Control Centers and America’s poison centers commend Procter and Gamble for this decision and call on other manufacturers of similar products to do the same.

“The Procter & Gamble product had been sold in clear packages in which the colorful packets were easily visible to children. Making the packaging opaque hopefully will help reduce the temptation of children to get into the product.

“In May 2012, poison centers first alerted the public about children 5 and younger becoming very ill after exposure to single-load laundry packets sold by several manufacturers. Since January 1 of this year, poison centers have managed nearly 5,000 cases of children 5 and younger exposed to laundry packets of various brands.

“New packaging alone won’t protect young children from these products. It’s also important for parents and caregivers always to keep laundry detergents locked up high and out of the reach of children, to follow the instructions on the product label, and to call their local poison center at 1-800-222-1222 immediately if they suspect a child has swallowed some of the detergent or gotten it into his or her eyes.”

More information about single-load laundry detergent packets is available on the AAPCC website at http://www.aapcc.org/alerts/laundry-detergent-packets/.

For more information, the media may contact Loreeta Canton, director of public relations and member services, at 703.894.1858 or canton(at)aapcc(dot)org; or Brett Schuster, communications associate, at 703.894.1858 or Schuster(at)aapcc(dot)org.

About the American Association of Poison Control Centers:

The AAPCC supports the nation’s 57 poison centers in their efforts to prevent and treat poison exposures. Poison centers offer free, confidential medical advice 24 hours a day, seven days a week through the Poison Help Line at 1-800-222-1222. This service provides a primary resource for poisoning information and helps reduce costly emergency department visits through in-home treatment.

To learn more, visit http://www.aapcc.org, like us on Facebook, follow us on Twitter, or read our blog at aapcc.wordpress.com. To join your voice with other poison center supporters, register for the AAPCC advocacy network at http://www.capwiz.com/aapcc – click on “Action E-List.”

– 30 –

Read the full story at http://www.prweb.com/releases/2013/7/prweb10923661.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. AAPCC Issues Statement on Decision of Urban Outfitters to Stop Selling Prescription-Themed Products
2. UCSF chancellor issues call-to-arms to patient advocates
3. Radiologists rank themselves as less than competent on health policy issues
4. Genetic abnormalities in benign or malignant tissues predict relapse of prostate cancer
5. FDA Issues Multiple Sclerosis Drug Alert
6. Quality of care, other issues may cause worse results in black prostate cancer surgery patients
7. U.S. Task Force Issues Blood Pressure Guidelines
8. Internists in Washington to discuss patient and professional issues in meetings on Capitol Hill
9. Cheaper drug could lead to serious eye issues
10. Insulite Labs announces the launch of the PCOS Inspiration Hour, a one hour virtual gathering place for women with PCOS and other women’s health issues to come together.
11. LawyersandSettlements.com Issues Report on Prostate Health Claim Lawsuits and Propecia Side Effect Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... “A Prophets Bones”: a thrilling adventure that reveals the mystery of ... were things that his parents and teachers had asked of him that he had neglected ... going to defy the Almighty Creator. There were some who would have felt themselves to ...
(Date:3/27/2017)... ... 27, 2017 , ... New patients who have sleep apnea in ... or without a referral. Sleep apnea is often left untreated because patients are not ... and chronic snoring. , Dr. Braasch seeks to raise awareness of sleep apnea ...
(Date:3/27/2017)... ... 27, 2017 , ... Drs. Bruce Trimble and Michelle Parker ... a referral. Trimble Dental offers a variety of services to meet each patient’s ... patients have discolored, crooked or missing teeth in Eau Claire, WI, Drs. Trimble ...
(Date:3/27/2017)... White Plains, NY (PRWEB) , ... March 27, 2017 , ... ... honoring Root Canal Awareness Week by teaching their patients about the key role this ... canal therapy from an experienced endodontist. To better serve those who need a ...
(Date:3/27/2017)... ... 2017 , ... This is the second major release since ... 2014. It is the culmination of collaborative efforts by members of the OSEHRA ... Member Zato Health co-funded the ONC certification and provided key technical support throughout ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... LEXINGTON, Mass. , March 27, 2017   Pulmatrix, ... innovative inhaled therapies to address serious pulmonary diseases, today announced ... allergic fungal disease, cystic fibrosis and asthma to its ... Richard B. Moss , MD, ... former Director of the Cystic Fibrosis Center at Stanford University, ...
(Date:3/27/2017)... March 27, 2017 The global ... USD 16.0 billion by 2025, according to a new ... of chronic diseases is anticipated to be responsible for ... thereby widens the scope for growth during the forecast ... population, which is highly susceptible to chronic diseases, is ...
(Date:3/27/2017)... and BOSTON , ... a leading global pharmaceutical company and Paratek Pharmaceuticals, ... the development and commercialization of innovative therapies based ... 3 trials of sarecycline for the treatment of ... primary efficacy endpoints. Sarecycline is a once-daily, oral, ...
Breaking Medicine Technology: